Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tadayoshi Shiraishi is active.

Publication


Featured researches published by Tadayoshi Shiraishi.


Biochemical and Biophysical Research Communications | 1989

Tyrosine phosphorylation in human neutrophil

Julian Gomez-Cambronero; Chi-Kuang Huang; Valerie A. Bonak; Ellen Wang; John E. Casnellie; Tadayoshi Shiraishi; R.I. Sha'afi

Protein tyrosine phosphorylation in human neutrophils was examined by immunoblotting with antibodies specific for phosphotyrosine. The addition of the human hormone granulocyte-macrophage colony stimulating factor to human neutrophils caused an increase in the tyrosine phosphorylation levels of several proteins. The increases in at least two of these proteins having molecular masses of 40 kDa (p40) and 54 kDa (p54) were rapid and were inhibited in pertussis toxin treated cells. The newly synthesized tyrosine kinase inhibitor ST 638 inhibited the increases in the levels of the tyrosine phosphorylation in p92, p78, p54 and p40 proteins. The epidermal growth factor receptor tyrosine kinase inhibitors were less effective. The addition of the chemotactic factor fMet-Leu-Phe to human neutrophils also caused an increase in tyrosine phosphorylation in some of these proteins. The pattern of the fMet-Leu-Phe-induced tyrosine phosphorylation was different from that produced by GM-CSF. The increases were also inhibited by ST 638. In addition, ST 638 inhibited superoxide production but not actin polymerization in control and GM-CSF-treated cells stimulated with fMet-Leu-Phe. Moreover, the active but not inactive phorbol esters increase the tyrosine phosphorylation only in the 40 kDa protein. These results suggest several points: (a) some of the responses produced by GM-CSF and fMet-Leu-Phe are mediated through tyrosine phosphorylation, (b) the GM-CSF receptor is coupled to a pertussis toxin sensitive G-protein, (c) the 40 kDa protein is probably the Gi alpha 2, and (d) the 78 or the 92 kDa protein is most likely the receptor for GM-CSF, which indicates that the receptor may have a tyrosine kinase domain.


Biochemical and Biophysical Research Communications | 1972

Crystalline enzyme which degrades the cell wall of living yeast

Shinpei Yamamoto; Tadayoshi Shiraishi; Susumu Nagasaki

Abstract An enzyme which degrades yeast glucan and the cell wall of living yeast was crystallized from the culture filtrate of a mold belonging to the genus Rhizopus . The enzyme appears to be homogeneous and has a molecular weight of 19,000. The exact bond split by the enzyme was not identified: however, from the studies on the enzymatic degradation products of yeast glucan and on the substrate specificity of the enzyme, it appears to act as a debranching enzyme cleaved glycosidic bond at the branch points in yeast glucan.


Biochemical and Biophysical Research Communications | 1987

Specific inhibitors of tyrosine-specific protein kinase, synthetic 4-hydroxycinnamamide derivatives

Tadayoshi Shiraishi; Takeshi Domoto; Naohiro Imai; Yoshio Shimada; Kiyoshi Watanabe


Archive | 1988

Hydroxystyrene compounds which are useful as tyrosine kinase inhibitors

Tadayoshi Shiraishi; Keiji Kameyama; Takeshi Domoto; Naohiro Imai; Yoshio Shimada; Yutaka Ariki; Kazunori Hosoe; Masaji Kawatsu; Ikuo Katsumi; Takayoshi Hidaka; Kiyoshi Watanabe


Archive | 1990

Hydroxystyrene compounds which have useful pharmaceutical utility

Tadayoshi Shiraishi; Keiji Kameyama; Takeshi Domoto; Naohiro Imai; Yoshio Shimada; Yutaka Ariki; Kazunoro Hosoe; Masaji Kawatsu; Ikuo Katsumi; Takayoshi Hidaka; Kiyoshi Watanabe


Archive | 1986

3-phenylthiomethylstyrene derivative, process for preparing the same, and antiallergic agent and tyrosinekinase inhibiting agent containing the same

Tadayoshi Shiraishi; Naohiro Imai; Takeshi Domoto; Keiji Kameyama; Takayoshi Hidaka; Kazunori Hosoe; Kiyoshi Watanabe; Ikuo Katsumi


Archive | 1985

3,5-DIISOPROPYLBENZYLIDENE HETEROCYCLIC COMPOUND

Yutaka Ariki; Naohiro Imai; Ikuo Katsumi; Tadayoshi Shiraishi; Katsuji Yamashita; Toshiaki Yamashita


Archive | 1990

1-phenyl-3,5-pyrazolidinedione hydroxystyrene compounds which have tyrosine kinase inhibiting activity

Tadayoshi Shiraishi; Keiji Kameyama; Takeshi Domoto; Naohiro Imai; Yoshio Shimada; Yutaka Ariki; Kazunori Hosoe; Masaji Kawatsu; Ikuo Katsumi; Takayoshi Hidaka; Kiyoshi Watanabe


Chemical & Pharmaceutical Bulletin | 1988

Specific Inhibitors of Tyrosine-Specific Protein Kinase. I. : Synthesis and Inhibitory Activities of α-Cyanocinnamamides

Tadayoshi Shiraishi; Keiji Kameyama; Naohiro Imai; Takeshi Domoto; Ikuo Katsumi; Kiyoshi Watanabe


Archive | 1991

Hydroxystyrene compounds having tyrosine kinase inhibiting activity

Tadayoshi Shiraishi; Keiji Kameyama; Takeshi Domoto; Naohiro Imai; Yoshio Shimada; Yutaka Ariki; Kazunori Hosoe; Masaji Kawatsu; Ikuo Katsumi; Takayoshi Hidaka; Kiyoshi Watanabe

Collaboration


Dive into the Tadayoshi Shiraishi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chi-Kuang Huang

University of Connecticut Health Center

View shared research outputs
Top Co-Authors

Avatar

Ellen Wang

University of Connecticut Health Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge